These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2126880)

  • 21. [Clinical study on prenatal cytogenetic analysis (author's transl)].
    Saito N
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Nov; 33(11):1971-80. PubMed ID: 6459394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chorionic villus needle sampling by the transabdominal route or by placental centesis. A series of 930 cases].
    Guidicelli B; Levy A; Piquet C; Gamerre M
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(8):851-5. PubMed ID: 8132961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cost-benefit analysis of the prevention of Down's syndrome by means of prenatal diagnosis during early pregnancy].
    Flatz VG
    Fortschr Med; 1978 Jun; 96(24):1255-6, 1295. PubMed ID: 149085
    [No Abstract]   [Full Text] [Related]  

  • 24. Midtrimester amniocentesis in twin pregnancies.
    Goldstein AI; Stills SM
    Obstet Gynecol; 1983 Nov; 62(5):659-61. PubMed ID: 6621955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal loss rate after second trimester amniocentesis at different gestational age.
    Saltvedt S; Almström H
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):10-4. PubMed ID: 9926885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-specific incidences of chromosome abnormalities at the second trimester amniocentesis for Japanese mothers aged 35 and older: collaborative study of 5484 cases.
    Yaegashi N; Senoo M; Uehara S; Suzuki H; Maeda T; Fujimori K; Hirahara F; Yajima A
    J Hum Genet; 1998; 43(2):85-90. PubMed ID: 9621511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Indications for amniocentesis for prenatal determination of fetal karyotype].
    Lur'e IV
    Tsitol Genet; 1976; 10(3):198-200. PubMed ID: 1014080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cost-benefit analysis of prenatal detection of Down syndrome and neural tube defects in older mothers.
    Sadovnick AD; Baird PA
    Am J Med Genet; 1981; 10(4):367-78. PubMed ID: 6460445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness ratio of chorionic villi biopsy for the prenatal diagnosis of chromosomal aberrations as compared with amniocentesis.
    Marchese CA; Viora E; Campogrande M; Carbonara AO
    Ric Clin Lab; 1986; 16(4):533-8. PubMed ID: 3107110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal genetic diagnosis following recurrent early pregnancy loss.
    Drugan A; Koppitch FC; Williams JC; Johnson MP; Moghissi KS; Evans MI
    Obstet Gynecol; 1990 Mar; 75(3 Pt 1):381-4. PubMed ID: 2406659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A 5-year review of prenatal diagnosis in Graz (author's transl)].
    Zierler H; Rosenkranz W; Winter R; Becker H
    Wien Klin Wochenschr; 1981 Feb; 93(3):75-80. PubMed ID: 6454304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
    Sharda S; Phadke SR
    J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal cytogenetic diagnosis. Amniotic cell culture versus chorionic villus sampling.
    Bell JA; Pearn JH; Smith A
    Med J Aust; 1987 Jan; 146(1):27-9. PubMed ID: 3796391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiety engendered by amniocentesis.
    Beeson D; Golbus MS
    Birth Defects Orig Artic Ser; 1979; 15(5C):191-7. PubMed ID: 526602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound-adjusted risk and spectrum of fetal chromosomal abnormality in women with elevated maternal serum alpha-fetoprotein.
    Megerian G; Godmilow L; Donnenfeld AE
    Obstet Gynecol; 1995 Jun; 85(6):952-6. PubMed ID: 7539525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five hundred cases of amniocentesis without bloody tap.
    Katayama KP; Roesler MR
    Obstet Gynecol; 1986 Jul; 68(1):70-3. PubMed ID: 3523332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome.
    Drugan A; Dvorin E; Koppitch FC; Greb A; Krivchenia EL; Evans MI
    Obstet Gynecol; 1989 Feb; 73(2):271-4. PubMed ID: 2463504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal diagnosis of uniparental disomy 15 following trisomy 15 mosaicism.
    Christian SL; Smith AC; Macha M; Black SH; Elder FF; Johnson JM; Resta RG; Surti U; Suslak L; Verp MS; Ledbetter DH
    Prenat Diagn; 1996 Apr; 16(4):323-32. PubMed ID: 8734806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical application of interphase FISH in prenatal diagnosis.
    Pergament E; Chen PX; Thangavelu M; Fiddler M
    Prenat Diagn; 2000 Mar; 20(3):215-20. PubMed ID: 10719324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.